Jiangsu Hengrui Pharmaceuticals - statistics & facts

Key insights

Jiangsu Hengrui's annual revenue in 2022
21.28bn CNY
Share of operating income contributed by anticancer drugs
53.3%
Share of operating income generated by direct sales in 2022
97.5%

Editor’s Picks
Editor’s Picks
Current statistics on this topic

Recommended statistics

Company positioning

Key company data

Research and development

Competitors

The oncology drug market

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)